Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
|
|
Celldex Therapeutics, Inc. (CLDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Cavanaugh Sarah (SVP OF CORP AFFAIRS & ADMIN.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 31,312 shares
@ $36.7342, valued at
$1.2M
Sold 1,355 shares
@ $36.3757, valued at
$49.3k
Exercised 31,312 options to buy
@ $2.78, valued at
$87k
Exercised 1,355 options to buy
@ $9.0165, valued at
$12.2k
|
|
| 08/19/2022 |
4
| Young Diane C. (SVP, CHIEF MEDICAL OFFICER) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 19,000 shares
@ $37.3008, valued at
$708.7k
Exercised 19,000 options to buy
@ $10.38, valued at
$197.2k
Exercised 45,000 options to buy
@ $2.71, valued at
$122k
|
|
| 08/17/2022 |
4
| Marucci Anthony S (PRESIDENT & CEO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 45,000 shares
@ $9.0165, valued at
$405.7k
Sold 120,000 shares
@ $37.6631, valued at
$4.5M
Exercised 75,000 options to buy
@ $2.78, valued at
$208.5k
Exercised 45,000 options to buy
@ $0 |
|
| 08/17/2022 |
4
| Wright Richard M. (SR. VP & CCO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 15,328 shares
@ $37.7119, valued at
$578k
Exercised 15,328 options to buy
@ $10.38, valued at
$159.1k
|
|
| 08/15/2022 |
4
| Martin Samuel Bates (SVP AND CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 2,453 shares
@ $37.0389, valued at
$90.9k
Sold 14,261 shares
@ $36.7649, valued at
$524.3k
Sold 2,065 shares
@ $35.3766, valued at
$73.1k
Sold 1,221 shares
@ $34.6206, valued at
$42.3k
Exercised 2,453 options to buy
@ $9.0165, valued at
$22.1k
Exercised 3,876 options to buy
@ $9.0165, valued at
$34.9k
Exercised 13,671 options to buy
@ $2.78, valued at
$38k
|
|
| 06/17/2022 |
4
| Wright Richard M. (SR. VP & CCO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 42,000 options to buy
@ $22.48, valued at
$944.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Cavanaugh Sarah (SVP OF CORP AFFAIRS & ADMIN.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 73,000 options to buy
@ $22.48, valued at
$1.6M
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Young Diane C. (SVP, CHIEF MEDICAL OFFICER) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 76,000 options to buy
@ $22.48, valued at
$1.7M
|
|
| 06/17/2022 |
4
| Crowley Elizabeth (SR. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 77,000 options to buy
@ $22.48, valued at
$1.7M
|
|
| 06/17/2022 |
4
| Martin Samuel Bates (SVP AND CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $22.48, valued at
$1.9M
|
|
| 06/17/2022 |
4
| PEPIN RONALD (SR. VP & CBO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $22.48, valued at
$337.2k
|
|
| 06/17/2022 |
4
| KELER TIBOR (EXECUTIVE VP & CSO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 91,000 options to buy
@ $22.48, valued at
$2M
|
|
| 06/17/2022 |
4
| Marucci Anthony S (PRESIDENT & CEO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $22.48, valued at
$5.6M
|
|
| 06/17/2022 |
4
| PENNER HARRY JR (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 13,600 options to buy
@ $22.48, valued at
$305.7k
|
|
| 06/17/2022 |
4
| CONRAD HERBERT J (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 13,600 options to buy
@ $22.48, valued at
$305.7k
|
|
| 06/17/2022 |
4
| Brownlie Keith L (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 13,600 options to buy
@ $22.48, valued at
$305.7k
|
|
| 06/17/2022 |
4
| MARINO JAMES J (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 13,600 options to buy
@ $22.48, valued at
$305.7k
|
|
| 06/17/2022 |
4
| Cohen Cheryl (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 27,200 options to buy
@ $22.48, valued at
$611.5k
|
|
| 06/17/2022 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 27,200 options to buy
@ $22.48, valued at
$611.5k
|
|
| 06/17/2022 |
4
| Shoos Karen L. (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 13,600 options to buy
@ $22.48, valued at
$305.7k
|
|
| 12/28/2021 |
4
| Martin Samuel Bates (SVP and CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 9,500 shares
@ $42, valued at
$399k
Exercised 3,250 options to buy
@ $9.0165, valued at
$29.3k
Exercised 3,750 options to buy
@ $2.78, valued at
$10.4k
|
|
| 12/10/2021 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 7,323 shares
@ $40, valued at
$292.9k
Exercised 1,857 options to buy
@ $9.0165, valued at
$16.7k
Exercised 5,466 options to buy
@ $10.38, valued at
$56.7k
|
|
| 12/10/2021 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 4,000 shares
@ $9.0165, valued at
$36.1k
Sold 4,000 shares
@ $40, valued at
$160k
Exercised 4,000 options to buy
@ $0 |
|
| 12/10/2021 |
4
| Heath-Chiozzi Margo (SVP of Regulatory Affairs) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 600 shares
@ $40, valued at
$24k
Exercised 600 options to buy
@ $2.78, valued at
$1.7k
|
|
| 11/17/2021 |
4
| Martin Samuel Bates (SVP and CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 7,452 shares
@ $43.923, valued at
$327.3k
Sold 2,048 shares
@ $42.2701, valued at
$86.6k
Exercised 3,250 options to buy
@ $9.0165, valued at
$29.3k
Exercised 3,750 options to buy
@ $2.78, valued at
$10.4k
|
|
| 11/16/2021 |
4
| Young Diane C. (SVP, Chief Medical Officer) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 4,600 shares
@ $42.9411, valued at
$197.5k
Exercised 4,600 options to buy
@ $10.38, valued at
$47.7k
|
|
| 11/03/2021 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 5,018 shares
@ $9.0165, valued at
$45.2k
Sold 4,302 shares
@ $44.113, valued at
$189.8k
Sold 901 shares
@ $43.061, valued at
$38.8k
Sold 2,120 shares
@ $41.619, valued at
$88.2k
Exercised 5,018 options to buy
@ $0
Exercised 938 options to buy
@ $2.78, valued at
$2.6k
|
|
| 11/03/2021 |
4
| Crowley Elizabeth (Sr. VP &CPDO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 2,528 shares
@ $44.116, valued at
$111.5k
Sold 600 shares
@ $43.113, valued at
$25.9k
Sold 1,189 shares
@ $41.616, valued at
$49.5k
Exercised 8,555 options to buy
@ $2.78, valued at
$23.8k
|
|
| 11/03/2021 |
4
| Heath-Chiozzi Margo (SVP of Regulatory Affairs) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Sold 600 shares
@ $41.71, valued at
$25k
Exercised 600 options to buy
@ $2.78, valued at
$1.7k
|
|
| 08/13/2021 |
4
| Heath-Chiozzi Margo (SVP of Regulatory Affairs) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 10,000 shares
@ $9.0165, valued at
$90.2k
Exercised 10,000 options to buy
@ $0 |
|
| 08/13/2021 |
4
| Jimenez Freddy A. (SVP & General Counsel) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Bought 430 shares
@ $46.28, valued at
$19.9k
|
|
|
|
|